Salient features of the study The authors searched Medline, the Cochrane Library, and relevant meeting abstracts (search done on April 9, 2014) for randomised trials that assessed bivalirudin versus heparin in patients planned for PCI Primary efficacy endpoint – incidence of major adverse cardiac events (MACE) up to 30 days Secondary efficacy endpoints – death,… Continue reading Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials
Preamble There is increasing interest in the association between vitamin D and atherosclerotic disease Low levels of vitamin D have been shown to be related to increased risk of stroke, myocardial infarction (MI), and total cardiovascular events Increased carotid IMT is a marker of structural atherosclerosis, which correlates with cardiovascular risk factors, and predicts cardiovascular… Continue reading Childhood 25-OH Vitamin D Levels and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study
Preamble of the study Statins are the cornerstone of hypercholesterolemia treatment Among statins, rosuvastatin is considered the most potent in beneficially modifying the serum lipid profile and altering LDL subfraction distribution On the other hand, statin treatment has been associated with the development of new-onset diabetes mellitus To date, it is unclear whether statin intervention… Continue reading The Effect of Rosuvastatin on Low-Density Lipoprotein Subfractions in Patients With Impaired Fasting Glucose J Cardiovasc Pharmacol Ther published online 18 September 2014
Preamble N-Acetylcysteine (NAC) is an anti-oxidant which potentiates the action of nitroglycerine When used with nitrates in the context of acute myocardial infarction, it may reduce infarct size by minimising reperfusion injury as well as potentiating nitroglycerine’s vasodilating and anti-platelet effects Salient Features The NACIAM trial – The early use of N-Acetyl Cysteine In Acute… Continue reading NACIAM trial: The early use of N-acetylcysteine (NAC) with glyceryl trinitrate (GTN) in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. European Society of Cardiology 2016 Congress; August 28, 2016; Rome, Italy. Abstract 2227
This is the excerpt for your very first post.